Press releases

  • Wednesday, 27 January 2016

    Ferring Pharmaceuticals and Karolinska Institutet sign collaboration agreement on the development of a Human Microbiome Translational Research Programme

    Read press release
  • Monday, 11 January 2016

    Targeted Immuno Therapies AB and Ferring Pharmaceuticals sign a strategic collaboration agreement for the treatment of IBD

    Read press release
  • Monday, 14 December 2015

    Cosmo & Ferring Pharmaceuticals enter into licensing agreement for CORTIMENT®MMX® (budesonide) in Japan

    Read press release
  • Friday, 11 December 2015

    Ferring Pharmaceuticals submits variation application to introduce new tailored dosing regimen in the PICOPREP® (sodium picosulfate, magnesium oxide, citric acid) label

    Read press release
Archive:

Helen Gallagher

Senior Director
Corporate Communications
Tel: +41 58 301 00 51

Nicole
Barraud-Estoppey

Senior Manager
Corporate Communications
Tel: +41 58 301 00 53

Corporate Communications

Ferring International Center S.A.
Ch. de la Vergognausaz 50
CH-1162 Saint-Prex
Switzerland
Tel: +41 58 301 00 00
Fax: +41 58 301 00 10


Email for media enquiries only.
For other queries, please see our Contact page.

Headquarters

Ferring International Center S.A.
Ch. de la Vergognausaz 50
1162 Saint-Prex
Switzerland

Tel:  +41 58 301 00 00
Fax: +41 58 301 00 10

Contact

GLOBAL LOCATOR